MaxCyte Inc

Change company Symbol lookup

Select an option...

MXCT MaxCyte Inc

RHI Robert Half International Inc

OUT OUTFRONT Media Inc

DIS Walt Disney Co

BONTQ Bon-Ton Stores Inc

DDS Dillard's Inc

BALTF iPath? Bloomberg Cotton Subindex Total Return(SM) ETN

SBLK Star Bulk Carriers Corp

NTAP NetApp Inc

ABMD ABIOMED Inc

Go

MaxCyte, Inc. is a commercial cell engineering company. The Company is focused on providing enabling platform technologies to advance cell-based research and development, as well as next-generation cell therapeutic discovery, development and commercialization. The Company has developed and commercialized its Flow Electroporation platform, which facilitates complex engineering of a variety of cells. Its ExPERT platform is based on its Flow Electroporation technology, which has been designed to address the cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. Its ExPERT platform consists of three instruments, which are known as the ATx, STx and GTx. The Company has also developed CARMA, a therapeutic platform based on transfecting mRNA into unstimulated cells for the development of immune cell therapies.